How can we help you?
Advice from our experts on best practices for collecting and using patient-experience data during the COVID-19 outbreak.
The consortium working on EMA-funded MINERVA Project to aid RWD use, is being led by RTI-HS
We've grown from 26 employees at RTP in 2000 to over 350 worldwide in 2020.
We'll help you navigate and understand the emerging ISPOR/ISPE Real World Evidence guidelines.
The paradigm of regenerative medicine development is changing. Our experienced team can help you stay on track.
Learn how a Market Access Evidence Roadmap can help you identify areas of evidence generation required to support reimbursement and increase access to your product.